Company Information

GODAVARI DRUGS LTD.

NSE : NABSE : 530317ISIN CODE : INE362C01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE102.001 (+0.99 %)
PREV CLOSE ( ) 101.00
OPEN PRICE ( ) 97.55
BID PRICE (QTY) 102.00 (183)
OFFER PRICE (QTY) 102.40 (85)
VOLUME 12565
TODAY'S LOW / HIGH ( )97.55 102.98
52 WK LOW / HIGH ( ) 76.21114
NSE
This Company is not listed in NSE
ChairmanGhanshyam Jaju
Managing DirectorMukund Kakani
Company SecretaryVenkatesh Achanta
Non Executive Independent DirectorSyed Anis Hussain
Vimala B Madon
Mahendra Uday Bhalerao
Dinesh Udpa
Whole Time DirectorMohit Jaju
Incorporation Year : 1987

Registered Office :

Address : 1-8-303/4,Mayfair,Sardar Patel Road Secunderabad,
Andhra Pradesh-500003 .

Phone : 040- 2784 9700 / 2784 2602 / 2784 4557

Industry : Pharmaceuticals & Drugs

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.